Role of MHC class-I antigens and the CD3 complex in the lysis of autologous human tumours by T-cell clones.
Affiliationepartment of Immunology, Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester M200 9BX, UK
MetadataShow full item record
AbstractPeripheral blood lymphocytes (PBL) of 4 patients with malignant effusions were stimulated for 6 days with purified autologous tumour cells, before isolation of the lymphoblasts and cloning by limiting dilution in interleukin-2 (IL-2). Forty-five clones were analyzed for cytotoxicity (CTX) against autologous, allogeneic tumour and erythromyeloid K562 cells of known status with respect to expression of major histocompatibility complex (MHC) antigens, estimated by reaction with the W6/32 (anti HLA, -A, -B, -C monomorphic) and TDR 31.1 (anti HLA-DR) monoclonal antibodies (MAb). All 45 clones were CD3+. Twenty-five (56%) of them were cytotoxic for at least one target; 24 were autoreactive (restricted in 7); 17 were alloreactive; 16 were K562 reactive. Under comparable conditions autoreactivity was partially blocked by W6/32 in 12/20 effector:target combinations; alloreactivity in 8/13 and K562 reactivity in 0/14. Modulation of effector cell surface CD3 antigens by OKT3 monitored by flow cytometry reduced autoreactivity in 9/14 combinations, alloreactivity in 2/6 and K562 reactivity in 0/4. W6/32 blocking and T3 modulation of cytotoxicity were almost invariably concordant against the same target. The data suggest that, to accomplish lysis of autologous and allogeneic tumour targets, certain clones require MHC recognition and a functional CD3 complex, while for others with similar target cell repertoires, there is no such requirement. It is possible that T-cell clones responding to a tumour-associated antigen (TAA) in the context of self MHC antigens can also respond to an allogeneic class-I product in the absence of TAA, and/or that aberrant class-I antigen expression on autologous tumours accounts for the alloreactivity.
CitationRole of MHC class-I antigens and the CD3 complex in the lysis of autologous human tumours by T-cell clones. 1987, 39 (4):436-41 Int J Cancer
JournalInternational Journal of Cancer
- Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
- Authors: de Vries JE, Spits H
- Issue date: 1984 Jan
- Melanoma cell lysis by human CTL clones: differential involvement of T3, T8 and HLA antigens.
- Authors: Fossati G, Anichini A, Parmiani G
- Issue date: 1987 Jun 15
- Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
- Authors: Aparicio P, Jaraquemada D, López de Castro JA
- Issue date: 1987 Feb 1
- Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
- Authors: Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB, Whiteside TL
- Issue date: 1991 Nov 15
- Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.
- Authors: Anichini A, Fossati G, Parmiani G
- Issue date: 1985 May 15